Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Drug Resistance

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 197 articles:
HTML format



Single Articles


    May 2020
  1. JOHNSON J, Robinson ML, Rajput UC, Valvi C, et al
    High Burden of Bloodstream Infections Associated with Antimicrobial Resistance and Mortality in the Neonatal Intensive Care Unit in Pune, India.
    Clin Infect Dis. 2020 May 18. pii: 5839743. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  2. MARURI F, Guo Y, Blackman A, van der Heijden YF, et al
    Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible M. tuberculosis isolates: a proposed threshold for identifying resistance.
    Clin Infect Dis. 2020 Apr 29. pii: 5827013. doi: 10.1093.
    PubMed     Abstract available


  3. WANG J, Foxman B, Pirani A, Lapp Z, et al
    Application of combined genomic and transfer analyses to identify factors mediating regional spread of antibiotic resistant bacterial lineages.
    Clin Infect Dis. 2020 Apr 2. pii: 5814952. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  4. BACHMANN LH, Kirkcaldy RD, Geisler WM, Wiesenfeld HC, et al
    Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations and symptom resolution following treatment of urethritis.
    Clin Infect Dis. 2020 Mar 18. pii: 5809308. doi: 10.1093.
    PubMed     Abstract available


  5. SRINIVASAN V, Ha VTN, Vinh DN, Thai PVK, et al
    Sources of multi-drug resistance in patients with previous isoniazid resistant tuberculosis identified using whole genome sequencing: A longitudinal cohort study.
    Clin Infect Dis. 2020 Mar 13. pii: 5804256. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  6. SATLIN MJ
    Languid Uptake of Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Infections and Continued Reliance on Polymyxins.
    Clin Infect Dis. 2020 Feb 20. pii: 5763081. doi: 10.1093.
    PubMed    


  7. KAUR R, Pham M, Yu KOA, Pichichero ME, et al
    Rising Pneumococcal Antibiotic Resistance in the Post 13-valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates from a Primary Care Setting.
    Clin Infect Dis. 2020 Feb 18. pii: 5739663. doi: 10.1093.
    PubMed     Abstract available


  8. EVANS ME, Roselle GA, Kralovic SM
    Contact Precautions for Methicillin-Resistant Staphylococcus aureus (MRSA) in Veterans Affairs Long-Term Care Facilities: Analysis of Policies not Practice.
    Clin Infect Dis. 2020 Feb 14. pii: 5735667. doi: 10.1093.
    PubMed    


    January 2020
  9. HARRIS AD, Morgan DJ, Pineles L, Magder L, et al
    Acquisition of antibiotic-resistant Gram-negative bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trial.
    Clin Infect Dis. 2020 Jan 23. pii: 5714298. doi: 10.1093.
    PubMed     Abstract available


  10. LEE BY, Bartsch SM, Hayden MK, Welling J, et al
    How to Choose Target Facilities in a Region to Implement Carbapenem-Resistant Enterobacteriaceae (CRE) Control Measures.
    Clin Infect Dis. 2020 Jan 23. pii: 5714274. doi: 10.1093.
    PubMed     Abstract available


  11. WHITTLES LK, White PJ, Didelot X
    Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics.
    Clin Infect Dis. 2020 Jan 6. pii: 5697289. doi: 10.1093/cid/ciz1241.
    PubMed     Abstract available


    December 2019
  12. PIEZZI V, Marschall J, Buetti N
    Are vancomycin-resistant enterococcal bloodstream infections associated with decreased survival?
    Clin Infect Dis. 2019 Dec 16. pii: 5678097. doi: 10.1093/cid/ciz1200.
    PubMed    


  13. BOURKE CD, Evans C
    Cotrimoxazole prophylaxis selects for antimicrobial resistance in HIV-exposed uninfected infants.
    Clin Infect Dis. 2019 Dec 13. pii: 5675116. doi: 10.1093/cid/ciz1193.
    PubMed    


  14. PERAGINE C, Walker SAN, Simor A, Walker SE, et al
    Impact of a comprehensive antimicrobial stewardship program on institutional burden of antimicrobial resistance: a 14-year controlled interrupted time series study.
    Clin Infect Dis. 2019 Dec 9. pii: 5669969. doi: 10.1093/cid/ciz1183.
    PubMed     Abstract available


    November 2019
  15. DICKSTEIN Y, Lellouche J, Schwartz D, Nutman A, et al
    Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms.
    Clin Infect Dis. 2019 Nov 23. pii: 5638072. doi: 10.1093/cid/ciz1146.
    PubMed     Abstract available


  16. SHIELDS RK, McCreary EK, Marini RV, Kline EG, et al
    Early experience with meropenem-vaborbactam for treatment of carbapenem-resistant Enterobacteriaceae infections.
    Clin Infect Dis. 2019 Nov 18. pii: 5628214. doi: 10.1093/cid/ciz1131.
    PubMed     Abstract available


  17. ECHOLS R, Ariyasu M, Nagata TD
    Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


  18. BONOMO RA
    Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


  19. NORDMANN P, Poirel L
    Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


  20. DOI Y
    Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


  21. LE BASTARD Q, Vangay P, Batard E, Knights D, et al
    US immigration is associated with rapid and persistent acquisition of antibiotic resistance genes in the gut.
    Clin Infect Dis. 2019 Nov 4. pii: 5611321. doi: 10.1093/cid/ciz1087.
    PubMed     Abstract available


    October 2019
  22. MORGAN DJ, Zhan M, Goto M, Franciscus C, et al
    The effectiveness of Contact Precautions on methicillin-resistant Staphylococcus aureus (MRSA) in long-term care across the United States.
    Clin Infect Dis. 2019 Oct 22. pii: 5601958. doi: 10.1093/cid/ciz1045.
    PubMed     Abstract available


  23. MACK I, Sharland M, Berkley JA, Klein N, et al
    Antimicrobial Resistance Following Azithromycin Mass Drug Administration: Potential Surveillance Strategies to Assess Public Health Impact.
    Clin Infect Dis. 2019 Oct 21. pii: 5572107. doi: 10.1093.
    PubMed     Abstract available


  24. KIRCHHELLE C, Dyson ZA, Dougan G
    A Biohistorical Perspective of Typhoid and Antimicrobial Resistance.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


  25. MERGENHAGEN KA, Starr KE, Wattengel BA, Lesse AJ, et al
    Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship.
    Clin Infect Dis. 2019 Oct 1. pii: 5579815. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  26. WEBB BJ, Majers J, Healy R, Jones PB, et al
    Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection.
    Clin Infect Dis. 2019 Sep 18. pii: 5571274. doi: 10.1093.
    PubMed     Abstract available


  27. O'HARA LM, Calfee DP, Miller LG, Pineles L, et al
    Optimizing Contact Precautions to Curb the Spread of Antibiotic-resistant Bacteria in Hospitals: A Multicenter Cohort Study to Identify Patient Characteristics and Healthcare Personnel Interactions Associated With Transmission of Methicillin-resistant
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


  28. STEVENS VW, Khader K, Echevarria K, Nelson RE, et al
    Use of oral vancomycin for Clostridioides difficile Infection (CDI) and the risk of vancomycin-resistant Enterococci (VRE).
    Clin Infect Dis. 2019 Sep 3. pii: 5559427. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  29. GOTTESMAN BS, Low M, Almog R, Chowers M, et al
    Quinolone Consumption by Mothers Increases their Children's Risk of Acquiring Quinolone-Resistant Bacteriuria.
    Clin Infect Dis. 2019 Aug 29. pii: 5556473. doi: 10.1093.
    PubMed     Abstract available


  30. JORGENSEN SCJ, Zasowski EJ, Trinh TD, Lagnf AM, et al
    Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study.
    Clin Infect Dis. 2019 Aug 12. pii: 5548921. doi: 10.1093.
    PubMed     Abstract available


  31. EDGEWORTH JD, Batra R, Wulff J, Harrison D, et al
    Reductions in methicillin-resistant Staphylococcus aureus,C. difficile infection and intensive care unit acquired bloodstream infection across the United Kingdom following implementation of a national infection control campaign.
    Clin Infect Dis. 2019 Aug 1. pii: 5542778. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  32. SUNDERMANN AJ, Babiker A, Marsh JW, Shutt KA, et al
    Outbreak of Vancomycin-resistant Enterococcus faecium in Interventional Radiology: Detection Through Whole Genome Sequencing-Based Surveillance.
    Clin Infect Dis. 2019 Jul 16. pii: 5532797. doi: 10.1093.
    PubMed     Abstract available


  33. TCHESNOKOVA VL, Rechkina E, Chan D, Haile HG, et al
    Pandemic uropathogenic fluoroquinolone-resistant Escherichia coli have enhanced ability to persist in the gut and cause bacteriuria in healthy women.
    Clin Infect Dis. 2019 Jul 4. pii: 5528138. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  34. SHARLING L, Marks SM, Goodman M, Chorba T, et al
    Rifampin-Resistant Tuberculosis In The United States, 1998-2014.
    Clin Infect Dis. 2019 Jun 22. pii: 5522413. doi: 10.1093.
    PubMed     Abstract available


  35. DYMOND A, Davies H, Mealing S, Pollit V, et al
    Genomic surveillance of methicillin-resistant Staphylococcus aureus: a mathematical early modelling study of cost effectiveness.
    Clin Infect Dis. 2019 Jun 18. pii: 5521015. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  36. TEMKIN E, Carmeli Y
    Zero or more: methodological challenges of counting and estimating deaths related to antibiotic-resistant infections.
    Clin Infect Dis. 2019 May 17. pii: 5491526. doi: 10.1093.
    PubMed     Abstract available


  37. LEE BY, Bartsch SM, Hayden MK, Welling J, et al
    How Introducing a Registry with Automated Alerts for Carbapenem-Resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a Region.
    Clin Infect Dis. 2019 May 9. pii: 5486092. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  38. KOBAYASHI M, Bigogo G, Kim L, Mogeni OD, et al
    Impact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009-2013.
    Clin Infect Dis. 2019 Apr 9. pii: 5432315. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  39. BURNHAM JP, Kakol MK, Vazquez Guillamet MC
    Methicillin-resistant Staphylococcus aureus Nasal Screening Adds Limited Value to the Choice of Empiric Antibiotics in Community-acquired Pneumonia.
    Clin Infect Dis. 2019;68:1251.
    PubMed    


  40. NIR-PAZ R, Gelman D, Khouri A, Sisson BM, et al
    Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination.
    Clin Infect Dis. 2019 Mar 14. pii: 5380636. doi: 10.1093.
    PubMed     Abstract available


  41. DYSON ZA, Klemm EJ, Palmer S, Dougan G, et al
    Antibiotic Resistance and Typhoid.
    Clin Infect Dis. 2019;68.
    PubMed     Abstract available


  42. KAUFHOLD S, Yaesoubi R, Pitzer VE
    Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance.
    Clin Infect Dis. 2019;68.
    PubMed     Abstract available


  43. RAOULT D, Rolain JM
    The paradigm of the Shadoks and antibiotic resistance.
    Clin Infect Dis. 2019 Mar 6. pii: 5369988. doi: 10.1093.
    PubMed    


    February 2019
  44. BOWER CW, Fridkin DW, Wolford HM, Slayton RB, et al
    Evaluating movement of patients with Carbapenem-Resistant Enterobacteriaceae infections in the Greater Atlanta Metropolitan Area using social network analysis.
    Clin Infect Dis. 2019 Feb 27. pii: 5365527. doi: 10.1093.
    PubMed     Abstract available


  45. SEE I, Mu Y, Albrecht V, Karlsson M, et al
    Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005-2013.
    Clin Infect Dis. 2019 Feb 25. pii: 5364550. doi: 10.1093.
    PubMed     Abstract available


  46. GRAVES KJ, Ghosh AP, Schmidt N, Augostini P, et al
    Trichomonas vaginalis virus (TVV) among women with trichomoniasis and associations with demographics, clinical outcomes, and metronidazole resistance.
    Clin Infect Dis. 2019 Feb 15. pii: 5320591. doi: 10.1093.
    PubMed     Abstract available


  47. NEUZIL KM, Pollard AJ, Marfin AA
    Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Clin Infect Dis. 2019;68.
    PubMed     Abstract available


  48. KARIUKI S, Mbae C, Onsare R, Kavai SM, et al
    Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
    Clin Infect Dis. 2019;68.
    PubMed     Abstract available


  49. LINDSAY S, Garrett D, Steele D
    Evidence to Action: The 10th International Conference on Typhoid and Other Invasive Salmonelloses.
    Clin Infect Dis. 2019;68.
    PubMed     Abstract available


  50. INAGAKI K, Lucar J, Blackshear C, Hobbs CV, et al
    Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus bacteremia - Nationwide Estimates of 30-day Readmission, In-hospital Mortality, Length of Stay, and Cost in the US.
    Clin Infect Dis. 2019 Feb 11. pii: 5315481. doi: 10.1093.
    PubMed     Abstract available


  51. CHOPRA S DR, Rizvi M Dr
    Antimicrobial Resistance in Low and Middle Income Countries.
    Clin Infect Dis. 2019 Feb 11. pii: 5314834. doi: 10.1093.
    PubMed    


  52. READ TRH, Fairley CK, Murray GL, Jensen JS, et al
    Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.
    Clin Infect Dis. 2019;68:554-560.
    PubMed     Abstract available


    January 2019
  53. ONG JJ, Magooa MP, Chikandiwa A, Kelly H, et al
    Prevalence and antimicrobial resistance of Mycoplasma genitalium infection among women living with HIV in South Africa: a prospective cohort study.
    Clin Infect Dis. 2019 Jan 29. pii: 5303854. doi: 10.1093.
    PubMed     Abstract available


  54. GRIFFITH DE
    Mycobacterium abscessus and antibiotic resistance: Same as it ever was.
    Clin Infect Dis. 2019 Jan 26. pii: 5301758. doi: 10.1093.
    PubMed    


  55. SHAW LP, Doyle RM, Kavaliunaite E, Spencer H, et al
    Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance profiles.
    Clin Infect Dis. 2019 Jan 26. pii: 5301759. doi: 10.1093.
    PubMed     Abstract available


  56. PAPANICOLAOU GA, Ustun C, Young JH, Chen M, et al
    Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.
    Clin Infect Dis. 2019 Jan 14. pii: 5289185. doi: 10.1093.
    PubMed     Abstract available


  57. PAUDYAL N, Yue M
    Antimicrobial Resistance in the "Dark Matter".
    Clin Infect Dis. 2019 Jan 7. pii: 5274640. doi: 10.1093.
    PubMed    


  58. TCHESNOKOVA VL, Rechkina E, Larson L, Ferrier K, et al
    Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193.
    Clin Infect Dis. 2019;68:334-337.
    PubMed     Abstract available


    December 2018
  59. TOTH H, Fesus A, Kungler-Goracz O, Balazs B, et al
    Utilization of vector autoregressive and linear transfer models to follow up the antibiotic resistance spiral in Gram-negative bacteria from cephalosporin consumption to colistin resistance.
    Clin Infect Dis. 2018 Dec 18. pii: 5252065. doi: 10.1093/cid/ciy1086.
    PubMed     Abstract available


  60. SCHUETZ AN
    Laboratory Antimicrobial Stewardship during an Outbreak of Linezolid- and Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Clin Infect Dis. 2018 Dec 4. pii: 5229260. doi: 10.1093/cid/ciy1023.
    PubMed    


    November 2018
  61. FALZON D, Jaramillo E, Gilpin C, Weyer K, et al
    The Role of Novel Approaches and New Findings in the Pharmacology of Tuberculosis Medicines in Improving Treatment Outcomes.
    Clin Infect Dis. 2018;67.
    PubMed    


  62. DESHPANDE D, Pasipanodya JG, Mpagama SG, Bendet P, et al
    Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  63. BLEASDALE SC
    Do We Need Another Study to Control Carbapenem-resistant Organisms, or Do We Just Need to Get Better at the Basics?
    Clin Infect Dis. 2018 Nov 23. pii: 5201668. doi: 10.1093.
    PubMed    


  64. TOMCZYK S, Zanichelli V, Grayson ML, Twyman A, et al
    Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.
    Clin Infect Dis. 2018 Nov 23. pii: 5201688. doi: 10.1093.
    PubMed     Abstract available


  65. DICKSTEIN Y, Lellouche J, Dalak Amar MB, Schwartz D, et al
    Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial.
    Clin Infect Dis. 2018 Nov 20. pii: 5193455. doi: 10.1093.
    PubMed     Abstract available


  66. CHEN Y, Sun L, Wu D, Wang H, et al
    Using Core-genome Multilocus Sequence Typing to Monitor the Changing Epidemiology of Methicillin-resistant Staphylococcus aureus in a Teaching Hospital.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  67. HU F, Zhu D, Wang F, Wang M, et al
    Current Status and Trends of Antibacterial Resistance in China.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  68. WANG Q, Wang X, Wang J, Ouyang P, et al
    Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  69. VAN DUIN D, Gu P, Dong J, Pfaff M, et al
    China-United States Research Collaborations in Antimicrobial Resistance.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  70. LIU L, Feng Y, Tang G, Lin J, et al
    Carbapenem-resistant Isolates of the Klebsiella pneumoniae Complex in Western China: The Common ST11 and the Surprising Hospital-specific Types.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  71. HUANG W, Qiao F, Zhang Y, Huang J, et al
    In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  72. WANG M
    Antimicrobial Resistance in China: Challenges and Actions.
    Clin Infect Dis. 2018;67.
    PubMed    


  73. XIE J, Yang Y, Huang Y, Kang Y, et al
    The Current Epidemiological Landscape of Ventilator-associated Pneumonia in the Intensive Care Unit: A Multicenter Prospective Observational Study in China.
    Clin Infect Dis. 2018;67.
    PubMed     Abstract available


  74. PETTIGREW MM, Gent JF, Kong Y, Halpin AL, et al
    Gastrointestinal microbiota disruption and risk of colonization with carbapenem-resistant Pseudomonas aeruginosa in ICU patients.
    Clin Infect Dis. 2018 Nov 1. pii: 5154869. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  75. ABBO L, Shukla BS, Giles A, Aragon L, et al
    Linezolid and Vancomycin-Resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome Sequencing.
    Clin Infect Dis. 2018 Oct 18. pii: 5136442. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  76. BRAUN DL, Hampel B, Kouyos R, Nguyen H, et al
    High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.
    Clin Infect Dis. 2018 Aug 13. pii: 5071945. doi: 10.1093.
    PubMed     Abstract available


  77. NELSON RE, Evans ME, Simbartl L, Jones M, et al
    Methicillin-resistant Staphylococcus aureus Colonization and Pre- and Post-hospital Discharge Infection Risk.
    Clin Infect Dis. 2018 Aug 11. pii: 5069896. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  78. THOMPSON JA, Kityo C, Dunn D, Hoppe A, et al
    Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.
    Clin Infect Dis. 2018 Jul 28. pii: 5060946. doi: 10.1093.
    PubMed     Abstract available


  79. GUNTHARD HF, Calvez V, Paredes R, Pillay D, et al
    Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.
    Clin Infect Dis. 2018 Jul 20. pii: 5055715. doi: 10.1093.
    PubMed     Abstract available


  80. BEN-DAVID D, Masarwa S, Fallach N, Temkin E, et al
    Success of a National Intervention in Controlling Carbapenem-Resistant Enterobacteriaceae in Israel's Long-Term Care Facilities.
    Clin Infect Dis. 2018 Jul 9. pii: 5050699. doi: 10.1093.
    PubMed     Abstract available


  81. CHEN XS, Yin YP, Li XY
    A ROADMAP plan to address research needs for gonococcal antimicrobial resistance in China.
    Clin Infect Dis. 2018 Jul 9. pii: 5050687. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  82. COLBY DJ, Kroon E, Sacdalan C, Gandhi M, et al
    Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis.
    Clin Infect Dis. 2018 Jun 29. pii: 5046792. doi: 10.1093.
    PubMed     Abstract available


  83. RANDOLPH AG, Xu R, Novak T, Newhams MM, et al
    Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children with Influenza-Related Critical Illness.
    Clin Infect Dis. 2018 Jun 9. pii: 5035208. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  84. RHEE SY, Clutter D, Fessel WJ, Klein D, et al
    Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance in a Large U.S. Clinic Population.
    Clin Infect Dis. 2018 May 26. pii: 5005024. doi: 10.1093.
    PubMed     Abstract available


  85. ESCANDON P, Chow NA, Caceres DH, Gade L, et al
    Molecular epidemiology of Candida auris in Colombia reveals a highly-related, country-wide colonization with regional patterns in Amphotericin B resistance.
    Clin Infect Dis. 2018 May 16. pii: 4996781. doi: 10.1093.
    PubMed     Abstract available


  86. KLEIN EY, Jiang W, Mojica N, Tseng KK, et al
    National Costs Associated with Methicillin-susceptible and Methicillin-resistant S. aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2018 May 12. pii: 4995458. doi: 10.1093.
    PubMed     Abstract available


  87. CASSONE M, Mantey J, Perri MB, Gibson K, et al
    Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus Aure and Vancomycin-Resistant Enterococcus Colonization.
    Clin Infect Dis. 2018 May 2. pii: 4991833. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  88. MACESIC N, Gomez-Simmonds A, Sullivan SB, Giddins MJ, et al
    Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.
    Clin Infect Dis. 2018 Apr 28. pii: 4990041. doi: 10.1093.
    PubMed     Abstract available


  89. ZAK-DORON Y, Dishon Benattar Y, Pfeffer I, Daikos GL, et al
    The Association between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: A Prospective Study.
    Clin Infect Dis. 2018 Apr 27. pii: 4987600. doi: 10.1093.
    PubMed     Abstract available


  90. SATLIN MJ, Chavda KD, Baker TM, Chen L, et al
    Colonization with Levofloxacin-Resistant Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
    Clin Infect Dis. 2018 Apr 26. pii: 4986473. doi: 10.1093.
    PubMed     Abstract available


  91. GUALANDI N, Mu Y, Bamberg WM, Dumyati G, et al
    Racial Disparities in Invasive Methicillin-Resistant Staphylococcus aureus Infections, 2005-2014.
    Clin Infect Dis. 2018 Apr 5. pii: 4961420. doi: 10.1093.
    PubMed     Abstract available


  92. MUKERJI SS, Misra V, Lorenz DR, Uno H, et al
    Impact of Antiretroviral Regimens on CSF Viral Escape in a Prospective Multicohort Study of ART-Experienced HIV-1 Infected Adults in the United States.
    Clin Infect Dis. 2018 Apr 3. pii: 4959767. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  93. BOJANG A, Camara B, Jagne Cox I, Oluwalana C, et al
    Long-term Impact of Oral Azithromycin taken by Gambian women during Labour on Prevalence and Antibiotic Susceptibility of S. pneumoniae and S. aureus in their Infants: Follow up of a Randomized Clinical Trial.
    Clin Infect Dis. 2018 Mar 28. pii: 4955815. doi: 10.1093.
    PubMed     Abstract available


  94. FULCHER JA, Du Y, Zhang TH, Sun R, et al
    Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir.
    Clin Infect Dis. 2018 Mar 21. pii: 4945456. doi: 10.1093.
    PubMed     Abstract available


  95. LI X, Arias CA, Aitken SL, Galloway Pena J, et al
    Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.
    Clin Infect Dis. 2018 Mar 12. pii: 4931590. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  96. RAY MJ, Lin MY, Tang AS, Arwady MA, et al
    Regional Spread of an Outbreak of Carbapenem-Resistant Enterobacteriaceae (CRE) through an Ego Network of Healthcare Facilities.
    Clin Infect Dis. 2018 Feb 3. pii: 4836930. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  97. YU MC, Chiang CY, Lee JJ, Chien ST, et al
    Treatment outcomes of multidrug-resistant tuberculosis in Taiwan: tackling loss to follow-up.
    Clin Infect Dis. 2018 Jan 31. pii: 4831095. doi: 10.1093.
    PubMed     Abstract available


  98. NIGO M, Luce AM, Arias CA
    Long Term Use of Tedizolid as Suppressive Therapy for Recurrent Methicillin-Resistant Staphylococcus aureus Graft Infection.
    Clin Infect Dis. 2018 Jan 23. pii: 4819116. doi: 10.1093.
    PubMed    


  99. KENYON C
    Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.
    Clin Infect Dis. 2018 Jan 23. pii: 4821305. doi: 10.1093.
    PubMed    


  100. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Moving Forward with Treatment of Gonorrhea for Users of HIV Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Clin Infect Dis. 2018 Jan 23. pii: 4821306. doi: 10.1093.
    PubMed    


  101. NADIMPALLI M, Delarocque-Astagneau E, Love DC, Price LB, et al
    Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries.
    Clin Infect Dis. 2018 Jan 15. pii: 4810441. doi: 10.1093.
    PubMed     Abstract available


  102. PARENTE DM, Cunha CB, Mylonakis E, Timbrook TT, et al
    The Clinical Utility of Methicillin Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis with Antimicrobial Stewardship Implications.
    Clin Infect Dis. 2018 Jan 11. pii: 4798927. doi: 10.1093.
    PubMed     Abstract available


  103. GORRIE CL, Mirceta M, Wick RR, Judd LM, et al
    Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital.
    Clin Infect Dis. 2018 Jan 11. pii: 4798841. doi: 10.1093.
    PubMed     Abstract available


  104. NACHEGA JB, Sam-Agudu NA, Mofenson LM, Schechter M, et al
    Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.
    Clin Infect Dis. 2018 Jan 8. pii: 4793055. doi: 10.1093.
    PubMed    


    December 2017
  105. TAIWO BO, Marconi VC, Berzins B, Moser CB, et al
    Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial.
    Clin Infect Dis. 2017 Dec 26. pii: 4775007. doi: 10.1093/cid/cix1131.
    PubMed     Abstract available


  106. STOCKDALE AJ, Saunders MJ, Boyd MA, Bonnett LJ, et al
    Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
    Clin Infect Dis. 2017 Dec 20. pii: 4767830. doi: 10.1093/cid/cix1108.
    PubMed     Abstract available


  107. YEGANEH N, Kerin T, Ank B, Watts H, et al
    HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
    Clin Infect Dis. 2017 Dec 19. pii: 4762480. doi: 10.1093/cid/cix1104.
    PubMed     Abstract available


  108. RAYMOND S, Nicot F, Pallier C, Bellecave P, et al
    Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
    Clin Infect Dis. 2017 Dec 13. pii: 4736156. doi: 10.1093/cid/cix1070.
    PubMed     Abstract available


  109. LIN MY, Hayden MK, Lyles RD, Lolans K, et al
    Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus among Adult Intensive Care Unit Patients following State-Mandated Active Surveillance.
    Clin Infect Dis. 2017 Dec 7. pii: 4706267. doi: 10.1093/cid/cix1056.
    PubMed     Abstract available


  110. WOUDT SHS, de Greeff SC, Schoffelen AF, Vlek ALM, et al
    Antibiotic resistance and the risk of recurrent bacteremia.
    Clin Infect Dis. 2017 Dec 7. pii: 4706269. doi: 10.1093/cid/cix1076.
    PubMed     Abstract available


    November 2017
  111. JUMARE J, Ndembi N, El-Kamary SS, Magder L, et al
    Cognitive function among antiretroviral treatment-naive individuals infected with HIV-1 Subtype G versus CRF02_AG in Nigeria.
    Clin Infect Dis. 2017 Nov 22. pii: 4647334. doi: 10.1093/cid/cix1019.
    PubMed     Abstract available


  112. HUMPHRIES RM, Hindler JA, Epson E, Horwich-Scholefield S, et al
    Carbapenem-resistant Enterobacteriaceae (CRE) detection practices in California: What are we missing?
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  113. HAWKEN SE, Washer LL, Williams CL, Newton DW, et al
    Genomic Investigation of a Putative Endoscope-Associated Carbapenem-Resistant Enterobacter cloacae Outbreak Reveals a Wide Diversity of Circulating Strains and Resistance Mutations.
    Clin Infect Dis. 2017 Oct 26. pii: 4565785. doi: 10.1093.
    PubMed     Abstract available


  114. TOLEMAN MS, Watkins ER, Williams T, Blane B, et al
    Investigation of a Cluster of Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Transmission in a Community Setting.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    PubMed     Abstract available


  115. BARBEE LA, Soge OO, Katz DA, Dombrowski JC, et al
    Increases in Neisseria gonorrhoeae with Reduced Susceptibility to Azithromycin among Men who have sex with Men (MSM), in Seattle, King County, Washington: 2012 - 2016.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    PubMed     Abstract available


  116. FARHAT MR, Jacobson KR, Franke MF, Kaur D, et al
    Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;65:1364-1370.
    PubMed     Abstract available


  117. ARDAL C, Rottingen JA, Opalska A, Van Hengel AJ, et al
    Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2017;65:1378-1382.
    PubMed     Abstract available


    September 2017
  118. DIONNE-ODOM J, Geisler WM, Aaron KJ, Waites KB, et al
    High Prevalence of Multidrug-Resistant Mycoplasma genitalium in HIV-infected Men who have Sex with Men in Alabama.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  119. COLLINS IJ
    Time to switch to second-line antiretroviral therapy in children with HIV in Europe and Thailand.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed    


  120. FRENCKEN JF, Wittekamp BHJ, Plantinga NL, Spitoni C, et al
    Associations Between Enteral Colonization With Gram-Negative Bacteria and Intensive Care Unit-Acquired Infections and Colonization of the Respiratory Tract.
    Clin Infect Dis. 2017 Sep 16. pii: 4159395. doi: 10.1093.
    PubMed     Abstract available


  121. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Abstract available


  122. GURIEVA T, Dautzenberg MJD, Gniadkowski M, Derde LPG, et al
    The transmissibility of antibiotic-resistant Enterobacteriaceae in Intensive Care Units.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Abstract available


  123. LEUNG V, Vincent C, Edens T, Miller M, et al
    Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Abstract available


  124. MILES-JAY A, Weissman SJ, Adler AL, Tchesnokova V, et al
    Epidemiology and antimicrobial resistance characteristics of the ST131-H30 subclone among extraintestinal Escherichia coli collected from US children.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Abstract available


  125. KATZ AR, Komeya AY, Kirkcaldy RD, Whelen AC, et al
    Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
    Clin Infect Dis. 2017;65:918-923.
    PubMed     Abstract available


  126. KOSSOW A, Kampmeier S, Willems S, Berdel WE, et al
    Control of Multidrug-Resistant Pseudomonas aeruginosa in Allogeneic Hematopoietic Stem Cell Transplant Recipients by a Novel Bundle Including Remodeling of Sanitary and Water Supply Systems.
    Clin Infect Dis. 2017;65:935-942.
    PubMed     Abstract available


  127. WOLF J, Tang L, Flynn PM, Pui CH, et al
    Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Clin Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Abstract available


  128. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Abstract available


    August 2017
  129. KNIGHT GM, Costelloe C, Murray KA, Robotham JV, et al
    Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden.
    Clin Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Abstract available


  130. TASHIRO M, Fushimi K, Kawano K, Takazono T, et al
    Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Abstract available


  131. ABAT C, Rolain JM, Dubourg G, Fournier PE, et al
    Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.
    Clin Infect Dis. 2017;65.
    PubMed     Abstract available


  132. MACESIC N, Nelson B, Uhlemann AC
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
    Clin Infect Dis. 2017;65:702-703.
    PubMed    


  133. JORDAN MR, Penazzato M, Cournil A, Vubil A, et al
    HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.
    Clin Infect Dis. 2017 Aug 8. doi: 10.1093.
    PubMed     Abstract available


  134. SCHECHTER MC, Bizune D, Kagei M, Machaidze M, et al
    Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Clin Infect Dis. 2017 Aug 3. doi: 10.1093.
    PubMed     Abstract available


    July 2017
  135. KLEINE CE, Schlabe S, Hischebeth GTR, Molitor E, et al
    Successful therapy of a multi-resistant EBSL (SHV-12)-producing and fluoroquinolone-resistant Salmonella enterica subsp. enterica serovar Typhi infection using combination therapy of meropenem and fosfomycin.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    PubMed     Abstract available


  136. KLEIN EY, Mojica N, Jiang W, Cosgrove SE, et al
    Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Abstract available


  137. AVERBUCH D, Tridello G, Hoek J, Mikulska M, et al
    Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Abstract available


  138. GEISSLER AL, Bustos Carrillo F, Swanson K, Patrick ME, et al
    Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2004-2012.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Abstract available


  139. SCHWABER MJ, Carmeli Y
    The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    PubMed     Abstract available


  140. FABRE V, Cosgrove SE
    A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel.
    Clin Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed    


    June 2017
  141. JIMENEZ A, Abbo L, Gebrezgi MT
    Importance of carbapenemase production detection in Carbapenem Resistant Enterobacteriaceae. Looking beyond epidemiological purposes.
    Clin Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed    


  142. KOULLIAS Y, Sax PE, Fields NF, Walensky RP, et al
    Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Abstract available


  143. LAMOTH F, Chung SJ, Damonti L, Alexander BD, et al
    Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
    Clin Infect Dis. 2017;64:1619-1621.
    PubMed     Abstract available


    May 2017
  144. LARSEN J, Petersen A, Larsen AR, Sieber RN, et al
    Emergence of livestock-associated methicillin-resistant Staphylococcus aureus bloodstream infections in Denmark.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    PubMed     Abstract available


  145. HOOK EW 3RD
    Continued Evolution of Gonococcal Antimicrobial Resistance.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed    


  146. FELD JJ, Ramji A, Shafran SD, Willems B, et al
    Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    PubMed     Abstract available


  147. CHO SY, Chung DR
    Infection Prevention Strategy in Hospitals in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A Review.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  148. APISARNTHANARAK A, Ratz D, Khawcharoenporn T, Patel PK, et al
    National Survey of Practices to Prevent Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Acinetobacter baumannii in Thailand.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  149. MARIMUTHU K, Venkatachalam I, Khong WX, Koh TH, et al
    Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  150. TEERAWATTANAPONG N, Kengkla K, Dilokthornsakul P, Saokaew S, et al
    Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  151. PRUETPONGPUN N, Khawcharoenporn T, Damronglerd P, Suwantarat N, et al
    Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  152. TARCHINI G, Liau KH, Solomkin JS
    Antimicrobial Stewardship in Surgery: Challenges and Opportunities.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  153. HONDA H, Ohmagari N, Tokuda Y, Mattar C, et al
    Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  154. MANSON AL, Abeel T, Galagan JE, Sundaramurthi JC, et al
    Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics.
    Clin Infect Dis. 2017 May 12. doi: 10.1093.
    PubMed     Abstract available


  155. SOCIAS ME, Nosova E, Kerr T, Hayashi K, et al
    Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Abstract available


  156. GANDRA S, Trett A, Klein EY, Laxminarayan R, et al
    Is Antimicrobial Resistance a Bigger Problem in Tertiary Care Hospitals than in Small Community Hospitals in the United States?
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Abstract available


  157. HEEMSKERK AD, Nguyen MTH, Dang HTM, Vinh Nguyen CV, et al
    Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Abstract available


  158. TOTH DJA, Khader K, Slayton RB, Kallen AJ, et al
    The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities.
    Clin Infect Dis. 2017 May 3. doi: 10.1093.
    PubMed     Abstract available


    April 2017
  159. RAVEN KE, Gouliouris T, Brodrick H, Coll F, et al
    Complex Routes of Nosocomial Vancomycin-Resistant Enterococcus faecium Transmission Revealed by Genome Sequencing.
    Clin Infect Dis. 2017;64:886-893.
    PubMed     Abstract available


  160. YANG S, Hemarajata P, Hindler J, Li F, et al
    Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.
    Clin Infect Dis. 2017;64:894-901.
    PubMed     Abstract available


  161. TAMMA PD, Rodriguez-Bano J
    The Use of Noncarbapenem beta-Lactams for the Treatment of Extended-Spectrum beta-Lactamase Infections.
    Clin Infect Dis. 2017;64:972-980.
    PubMed     Abstract available


    March 2017
  162. HEO ST, Tatara AM, Jimenez-Ortigosa C, Jiang Y, et al
    Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999-2015).
    Clin Infect Dis. 2017 Mar 31. doi: 10.1093.
    PubMed     Abstract available


  163. BILINSKI J, Grzesiowski P, Sorensen N, Madry K, et al
    Fecal Microbiota Transplantation in Patients with Blood Disorders Inhibits Gut Colonization with Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Abstract available


  164. WEBB BJ, Healy R, Majers J, Burr Z, et al
    Prediction of Bloodstream Infection due to Vancomycin-Resistant Enterococci in Patients Undergoing Leukemia Induction or Hematopoietic Stem Cell Transplantation.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Abstract available


  165. VAN HECKE O, Wang K, Lee JJ, Roberts NW, et al
    The implications of antibiotic resistance for patients' recovery from common infections in the community: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Abstract available


  166. TSALIK EL, Petzold E, Kreiswirth BN, Bonomo RA, et al
    Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  167. ANDERSON DJ, Jenkins TC, Evans SR, Harris AD, et al
    The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  168. DOI Y, Bonomo RA, Hooper DC, Kaye KS, et al
    Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  169. DOERNBERG SB, Lodise TP, Thaden JT, Munita JM, et al
    Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  170. HUVANE J, Komarow L, Hill C, Tran TT, et al
    Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  171. MANCA C, Hill C, Hujer AM, Patel R, et al
    Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  172. CROSS HR, Harris A, Arias RM, Chambers HF, et al
    Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  173. CHAMBERS HF, Cross HR, Evans SR, Kreiswirth BN, et al
    The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Clin Infect Dis. 2017;64.
    PubMed     Abstract available


  174. MURRAY BE, Jezek A
    The Antibacterial Resistance Leadership Group: First Steps.
    Clin Infect Dis. 2017;64.
    PubMed    


  175. MUNITA JM, Aitken SL, Miller WR, Perez F, et al
    Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Abstract available


  176. MARKS SM, Mase SR, Bamrah Morris S
    Systematic Review, Meta-Analysis, and Cost Effectiveness of Treatment of Latent Tuberculosis Infection to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Abstract available


  177. HEZODE C, Fourati S, Chevaliez S, Scoazec G, et al
    Sofosbuvir-Daclatasvir-Simeprevir plus Ribavirin in Direct-Acting Antiviral-Experienced Hepatitis C Patients.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Abstract available


  178. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Abstract available


  179. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Abstract available


  180. SEE I, Wesson P, Gualandi N, Dumyati G, et al
    Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.
    Clin Infect Dis. 2017;64:597-604.
    PubMed     Abstract available


    February 2017
  181. THOMPSOM CN, Karkey A, Dongol S, Ariyal A, et al
    Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2,092 participants enrolled into four randomised controlled trials in Nepal.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Abstract available


  182. ONG DS, Frencken JF, Klein Klouwenberg PM, Juffermans N, et al
    Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: a prospective observational cohort study.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Abstract available


  183. JOHNSTON JC, Campbell JR, Menzies D
    Effect of intermittency on treatment outcomes in pulmonary tuberculosis: an updated systematic review and meta-analysis.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    PubMed    


  184. JACOBSON KR, Barnard M, Kleinman MB, Streicher EM, et al
    Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed    


  185. ROHDE AM, Gastmeier P
    Optimizing Proton Pump Inhibitor Use to Reduce Antimicrobial Resistance Rates?
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed    


  186. KOH WJ, Jeong BH, Kim SY, Jeon K, et al
    Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Clin Infect Dis. 2017;64:309-316.
    PubMed     Abstract available


  187. READ TR, Fairley CK, Tabrizi SN, Bissessor M, et al
    Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Clin Infect Dis. 2017;64:250-256.
    PubMed     Abstract available


  188. PATEL R, Tsalik EL, Petzold E, Fowler VG Jr, et al
    MASTERMIND: Bringing Microbial Diagnostics to the Clinic.
    Clin Infect Dis. 2017;64:355-360.
    PubMed     Abstract available


  189. MOEHRING RW, Anderson DJ, Cochran RL, Hicks LA, et al
    Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings.
    Clin Infect Dis. 2017;64:377-383.
    PubMed     Abstract available


    January 2017
  190. CHUANG YC, Lin HY, Chen PY, Lin CY, et al
    Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Abstract available


    December 2016
  191. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    October 2016
  192. LOCKHART SR, Etienne KA, Vallabhaneni S, Farooqi J, et al
    Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    September 2016
  193. LAVERGNE RA, Chouaki T, Hagen F, Toublanc B, et al
    Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    August 2016
  194. GREBELY J, Dore GJ, Zeuzem S, Aspinall RJ, et al
    Efficacy and safety of sofosbuvir/velpatasvir in patients with chronic hepatitis C virus infection receiving opioid substitution therapy: Analysis of Phase 3 ASTRAL trials.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    June 2016
  195. WALKER E, Lyman A, Gupta K, Mahoney MV, et al
    Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


  196. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


    May 2016
  197. KNISELY JM, Liu B, Ranallo RT, Zou L, et al
    Vaccines for Hospital-Associated Infections: Promise and Challenge.
    Clin Infect Dis. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: